Magnolia Medical Technologies

Medical Devices & EquipmentSeries CSeattle, USmagnolia-medical.com

Latest round

Series C

Last raised

Dec 2018

Total raised

$47M

Investors

5

About Magnolia Medical Technologies

Magnolia Medical Technologies, Inc.Magnolia Medical Technologies, Inc. specializes in the development of diagnostic tools for sepsis testing.00 mn from Horizon Technology Finance in October 2022.Magnolia Medical Technologies specializes in innovative diagnostic solutions aimed at enhancing the accuracy of sepsis testing and reducing blood culture contamination. Their flagship product, the Steripath® Initial Specimen Diversion Device® (ISDD®), is FDA-cleared and designed to minimize contamination during blood culture collections, with clinical studies demonstrating significant reductions in contamination rates—reportedly between 83% and 88%—when used in both peripheral venipuncture and intravenous line starts. The company also offers the Steripath Micro for pediatric patients, expanding its application across diverse patient demographics.Magnolia Medical Technologies operates on a B2B model, primarily engaging with hospitals and healthcare systems that seek to improve their diagnostic processes and patient care standards. The company generates revenue through the sale of proprietary devices, including the Steripath® ISDD®, and associated educational resources for healthcare professionals. Transactions typically occur through direct sales with healthcare providers, ensuring integration into hospital supply chains for frontline medical staff. The firm is focused on launching upcoming products aimed at further enhancing sepsis testing capabilities. Additionally, Magnolia Medical plans to expand its reach into new markets and geographic regions, targeting hospitals and healthcare systems that face challenges related to sepsis misdiagnosis. The upcoming initiatives are expected to position the company for growth in both existing and new markets.

Who invested in Magnolia Medical Technologies

5 investors across 4 rounds

See all investors in Magnolia Medical Technologies

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series C

    Dec 18, 2018

    Amount

    $20M

    Investors

    Locked

  2. Series B

    Apr 4, 2017

    Amount

    $7.3M

    Investors

    Locked

  3. Series B

    Jul 13, 2016

    Amount

    $14M

    Investors

    Locked

  4. Series A

    May 19, 2015

    Amount

    $6.2M

    Investors

    Locked

Questions about Magnolia Medical Technologies

Who invested in Magnolia Medical Technologies?

Magnolia Medical Technologies has 5 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Magnolia Medical Technologies raised?

Magnolia Medical Technologies has raised 4 venture rounds. Sign up free to see how much each round raised and the total.

When did Magnolia Medical Technologies last raise money?

Magnolia Medical Technologies's most recent round on record is a Series C, in Dec 2018.

What does Magnolia Medical Technologies do?

Magnolia Medical Technologies, Inc.

Where is Magnolia Medical Technologies headquartered?

Magnolia Medical Technologies is headquartered in Seattle, US.

Which VCs invest in companies like Magnolia Medical Technologies?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at Magnolia Medical Technologies's stage. Their profiles are linked below.

Raising like Magnolia Medical Technologies? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.